230 related articles for article (PubMed ID: 2354150)
1. Human alpha- to zeta-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retained.
Brezniak DV; Brower MS; Witting JI; Walz DA; Fenton JW
Biochemistry; 1990 Apr; 29(14):3536-42. PubMed ID: 2354150
[TBL] [Abstract][Full Text] [Related]
2. Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities.
Sonder SA; Fenton JW
Clin Chem; 1986 Jun; 32(6):934-7. PubMed ID: 3708816
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-specific inhibition by and slow cleavage of hirulog-1.
Witting JI; Bourdon P; Brezniak DV; Maraganore JM; Fenton JW
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):737-43. PubMed ID: 1290488
[TBL] [Abstract][Full Text] [Related]
4. Catalytically competent human and bovine zeta-thrombin and chimeras generated from unfolded polypeptide chains.
Lewis SD; Brezniak DV; Fenton JW; Shafer JA
Protein Sci; 1992 Aug; 1(8):998-1006. PubMed ID: 1304387
[TBL] [Abstract][Full Text] [Related]
5. Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition.
Fenton JW; Olson TA; Zabinski MP; Wilner GD
Biochemistry; 1988 Sep; 27(18):7106-12. PubMed ID: 3196704
[TBL] [Abstract][Full Text] [Related]
6. [The critical role of the interaction of anion-binding thrombin exosite with complementary segment of the Aalpha-chain of fibrinogen in detecting high specificity of the enzyme].
Sereĭskaia AA; Smirnova IV; Karabut LV; Chetyrkina SN
Biokhimiia; 1994 Mar; 59(3):360-7. PubMed ID: 8180269
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a membrane protease from rat submaxillary-gland mitochondria that possess thrombin-like activity.
Bharadwaj M; Bharadwaj D; Hati RN
Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):193-9. PubMed ID: 8546683
[TBL] [Abstract][Full Text] [Related]
8. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G.
Molino M; Blanchard N; Belmonte E; Tarver AP; Abrams C; Hoxie JA; Cerletti C; Brass LF
J Biol Chem; 1995 May; 270(19):11168-75. PubMed ID: 7744748
[TBL] [Abstract][Full Text] [Related]
9. The action of thrombin on peptide p-nitroanilide substrates: hydrolysis of Tos-Gly-Pro-Arg-pNA and D-Phe-Pip-Arg-pNA by human alpha and gamma and bovine alpha and beta-thrombins.
Lottenberg R; Hall JA; Fenton JW; Jackson CM
Thromb Res; 1982 Nov; 28(3):313-32. PubMed ID: 7179220
[TBL] [Abstract][Full Text] [Related]
10. Human alpha- and gamma-thrombin specificity with tripeptide p-nitroanalide substrates under physiologically relevant conditions.
Witting JI; Miller TM; Fenton JW
Thromb Res; 1987 May; 46(4):567-74. PubMed ID: 3617013
[TBL] [Abstract][Full Text] [Related]
11. Proflavin binding within the fibrinopeptide groove adjacent to the catalytic site of human alpha-thrombin.
Sonder SA; Fenton JW
Biochemistry; 1984 Apr; 23(8):1818-23. PubMed ID: 6722124
[TBL] [Abstract][Full Text] [Related]
12. Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II. Bovine chymotrypsin A alpha, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester substrates.
Harper JW; Cook RR; Roberts CJ; McLaughlin BJ; Powers JC
Biochemistry; 1984 Jun; 23(13):2995-3002. PubMed ID: 6380580
[TBL] [Abstract][Full Text] [Related]
13. Human neutrophil elastase alters human alpha-thrombin function: limited proteolysis near the gamma-cleavage site results in decreased fibrinogen clotting and platelet-stimulatory activity.
Brower MS; Walz DA; Garry KE; Fenton JW
Blood; 1987 Mar; 69(3):813-9. PubMed ID: 3101765
[TBL] [Abstract][Full Text] [Related]
14. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters.
Oleksyszyn J; Powers JC
Biochemistry; 1991 Jan; 30(2):485-93. PubMed ID: 1988040
[TBL] [Abstract][Full Text] [Related]
15. Interaction of heparin cofactor II with neutrophil elastase and cathepsin G.
Pratt CW; Tobin RB; Church FC
J Biol Chem; 1990 Apr; 265(11):6092-7. PubMed ID: 2318847
[TBL] [Abstract][Full Text] [Related]
16. Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption.
Thomas VA; Wheeless CJ; Stack MS; Johnson DA
Biochemistry; 1998 Feb; 37(8):2291-8. PubMed ID: 9485375
[TBL] [Abstract][Full Text] [Related]
17. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
Car BD; Baggiolini M; Walz A
Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
[TBL] [Abstract][Full Text] [Related]
18. Catalytic properties of serine proteases. 2. Comparison between human urinary kallikrein and human urokinase, bovine beta-trypsin, bovine thrombin, and bovine alpha-chymotrypsin.
Ascenzi P; Menegatti E; Guarneri M; Bortolotti F; Antonini E
Biochemistry; 1982 May; 21(10):2483-90. PubMed ID: 7046788
[TBL] [Abstract][Full Text] [Related]
19. New, sensitive fluorogenic substrates for human cathepsin G based on the sequence of serpin-reactive site loops.
Réhault S; Brillard-Bourdet M; Juliano MA; Juliano L; Gauthier F; Moreau T
J Biol Chem; 1999 May; 274(20):13810-7. PubMed ID: 10318785
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets.
Goel MS; Diamond SL
J Biol Chem; 2003 Mar; 278(11):9458-63. PubMed ID: 12524437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
